Production (Stage)
BriaCell Therapeutics Corp.
BCT.TO
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.71% | -57.55% | -95.94% | -96.68% | -81.36% |
| Total Receivables | 7,039.20% | 11,240.19% | -- | 2.01% | 238.20% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -63.92% | 247.43% | 1,173.24% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -39.00% | -55.35% | -86.44% | -81.26% | -65.40% |
|
|
|||||
| Total Current Assets | -39.00% | -55.35% | -86.44% | -81.26% | -65.40% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -7.33% | -7.24% | -7.11% | -6.99% | -6.87% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -23.44% | -44.07% | -78.38% | -79.13% | -64.20% |
|
|
|||||
| Total Accounts Payable | 34.80% | 875.80% | 538.14% | 545.27% | 537.17% |
| Total Accrued Expenses | 6.90% | 23.20% | -57.15% | -13.51% | 141.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 33.29% | 376.69% | 314.17% | 388.60% | 485.37% |
|
|
|||||
| Total Current Liabilities | 33.29% | 376.69% | 314.17% | 388.60% | 485.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -94.55% | -88.62% | -96.24% | -83.41% | -52.19% |
| Total Liabilities | -70.14% | -58.38% | -72.34% | -65.08% | -42.02% |
|
|
|||||
| Common Stock & APIC | 22.79% | 5.84% | 3.70% | -3.98% | -3.61% |
| Retained Earnings | -13.49% | -22.23% | -5.94% | -7.66% | -17.19% |
| Treasury Stock & Other | 89.47% | 9,651.41% | 49.59% | 6,352.85% | 6,070.08% |
| Total Common Equity | 144.63% | 48.55% | 36.93% | -1.24% | -530.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 144.63% | 48.55% | 36.93% | -1.24% | -530.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -53.85% | -60.70% | -- | -- | -- |
| Total Equity | 138.80% | 47.56% | 28.92% | -5.78% | -549.50% |
|
|
|||||